RECURSION PHARMACEUTICALS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $67.4M | $610.3M | $285.1M |
| FY2022 | $215.5M | $701.3M | $549.9M |
| FY2023 | $190.3M | $653.7M | $391.6M |
| FY2024 | $413.8M | $1.45B | $594.4M |
| FY2025 | $343.3M | $1.47B | $743.3M |